Authors:
Liliane Kouabla Siransy Felix Houphouet Boigny University, Abidjan, Côte d’Ivoire

Search for other papers by Liliane Kouabla Siransy in
Current site
Google Scholar
PubMed
Close
,
Zizendorf Yves Nanga Felix Houphouet Boigny University, Abidjan, Côte d’Ivoire
National Public Health Laboratory, Abidjan, Côte d’Ivoire

Search for other papers by Zizendorf Yves Nanga in
Current site
Google Scholar
PubMed
Close
,
Flore Sandrine Zaba Central Laboratory of the University Hospital of Yopougon, Côte d’Ivoire

Search for other papers by Flore Sandrine Zaba in
Current site
Google Scholar
PubMed
Close
,
Nyasenu Yawo Tufa University Hospital Sylvanus Olympio, Togo

Search for other papers by Nyasenu Yawo Tufa in
Current site
Google Scholar
PubMed
Close
, and
Sery Romuald Dasse Felix Houphouet Boigny University, Abidjan, Côte d’Ivoire

Search for other papers by Sery Romuald Dasse in
Current site
Google Scholar
PubMed
Close
Open access

Hepatitis B and HIV infection are two viral infections that represent real global public health problems. In order to improve their management, some hypotheses suggest that genetic predispositions like ABO and Rh blood groups would influence the occurrence of these diseases.

The aim of the present study was to examine the association between ABO and Rhesus blood groups and the susceptibility to HIV infection and hepatitis B.

We conducted a cross-sectional and analytical study in a population of voluntary blood donors in the Blood Transfusion Center of Abidjan. All blood donors who donated blood between January and June 2014 were tested for HBs antigen and anti-HIV antibodies (ELISA tests) and were ABO typed.

The total number of examined blood donors during this period was 45,538, of which 0.32% and 8.07% were respectively infected with HIV and hepatitis B virus. O-group donors were more infected than non-O donors.

Our study is an outline concerning the search for a link between ABO and Rh blood groups and hepatitis B and HIV infection. Further studies should be conducted to confirm the interaction between these two infections and contribute to the search for new therapeutic approaches.

  • 1.

    PNPEC: Care Guide for People Living with HIV, p. 93 (2009)

  • 2.

    World Health Organization, VIH/SIDA. Checklist No. 360 (2015)

  • 3.

    Aubry P : Hépatites virales en zones tropicales. Actualités 2012. Med Trop, 8 (2013)

  • 4.

    Enel C , Desgrées LA, N’dri Yoman T, Danel C, Larmarange J: Les hépatites virales B et C en Côte d’Ivoire: l’urgence d’une dynamisation de la lutte. J Afr Hepatol Gastroenterol 10, 15 (2015)

    • Search Google Scholar
    • Export Citation
  • 5.

    Sayal SK , Das AL, Nema SK: Study of blood groups in HIV seropositive patients. Ind J Derm Ven Lepr 62, 295297 (1996)

  • 6.

    Roberts F : Blood groups and susceptibility to disease: a review. Br J Prev Soc Med 11, 107125 (1957)

  • 7.

    Qiang Li CY , Jin-Hong Y, Li Liu, Shuang-Shuang X, Wen-Wen L, Xia Y, Wen-Bo F, Zhong-Tao G, Shi-Jun C, Naoya K: ABO blood group and the risk of hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. PLoS One 7, (2012)

    • Search Google Scholar
    • Export Citation
  • 8.

    Alo MN , Eze UA, Yaro SA, Jubril B, Nwanoke NN: Relationship between ABO and Rhesus blood groups and susceptibility to asthma within Sokoto Metropolis, Nigeria. Int J Immunol 3, 3741 (2015)

    • Search Google Scholar
    • Export Citation
  • 9.

    Szmuness W , Prince AM, Cherubin CE: Serum hepatitis antigen (SH) carrier state: relation to ABO blood groups. Br Med J 2, 198199 (1971)

    • Search Google Scholar
    • Export Citation
  • 10.

    Emeribe AO , Ejezie GC: ABO blood groups distribution in relation to hepatitis B surface antigen and the presence of lipoidophil antibodies. East Afr Med J 69, 1461488 (1992)

    • Search Google Scholar
    • Export Citation
  • 11.

    Onsten TGH , Callegari-Jacques SM, Goldani LZ: The higher frequency of blood group B in a Brazilian population with HIV infection. Open AIDS J 7, 4750 (2013)

    • Search Google Scholar
    • Export Citation
  • 12.

    N’dri N , Thot’o AS, Okon AJ, Assi C, Allah-Kouadio E, Soro D, Diakité M, Koné A, Koné S, Lohouès-Kouacou MJ, Camara BM: Prevalence of HBs Ag among blood donors in Transfusion Center, Abidjan (Ivory Coast). Open J Gastroenterol 3, 165169 (2013)

    • Search Google Scholar
    • Export Citation
  • 13.

    Kra O , N’dri N, Ehui E, Ouattara B, Bissagnene E: Prévalence de l’antigène HBs chez les donneurs de sang au centre régional de transfusion sanguine de Bouaké (Côte d’Ivoire) en 2001. Bull Soc Pathol Exot 100, 127129 (2007)

    • Search Google Scholar
    • Export Citation
  • 14.

    Dembélé B , Inwoley K, Kouamé K, Siransy B, Diane M, Kpangni J: Les fréquences phénotypiques et génotypiques des systèmes ABO et Rhésus (d) dans la population ivoirienne. Cah Santé Publique 8, 4149 (2009)

    • Search Google Scholar
    • Export Citation
  • 15.

    Assi C , Allah-Kouadio E, Ouattara A, Diakité M, Koné S, Lohoues-Kouacou MJ, Camara BM: Vaccination coverage against the hepatitis B and prevalence of HBs Ag: a crosssectional study involving 592 persons attending public screening in Abidjan. Clin Res Hepatol Gastroenterol 35, 506507 (2011)

    • Search Google Scholar
    • Export Citation
  • 16.

    Ehoussou K , Tiembre I, Benie J, N’doutabe M, Dagnan S, Djeha D, Tagliante-Saracino J: Évaluation de la séroprévalence de l’infection à VIH et à VHB chez les donneurs de sang militaires à Abidjan. Med Afr Noire 44, 12 (1997)

    • Search Google Scholar
    • Export Citation
  • 17.

    Sanou M : Séroprévalence des VIH, VHB, VHC et syphilis chez les donneurs de sang au centre régional de transfusion sanguine de Koudougou au Burkina Faso en 2009. Transfus Clin Biol 18, 338419 (2011)

    • Search Google Scholar
    • Export Citation
  • 18.

    Lewkonia RM , Ronald F: ABO blood group distribution in serum hepatitis. Br Med J 3, 268269 (1969)

  • 19.

    Zuckerman AJ , Mcdonald JC: ABO blood groups and acute hepatitis. Br Med J 31, 537538 (1963)

  • 20.

    Ehlers H : Interview du Docteur Heinrich Krener sur le SIDA et le cancer. Raum & Zeit No. 114 (2001)

  • Collapse
  • Expand

Senior editors

Editor(s)-in-Chief: Dunay, Ildiko Rita, Prof. Dr. Pharm, Dr. rer. nat., University of Magdeburg, Germany

Editor(s)-in-Chief: Heimesaat, Markus M., Prof. Dr. med., Charité - University Medicine Berlin, Germany

Editorial Board

  • Berit Bangoura, Dr. DVM. PhD,  University of Wyoming, USA
  • Stefan Bereswill, Prof. Dr. rer. nat., Charité - University Medicine Berlin, Germany
  • Dunja Bruder, Prof. Dr. rer. nat., University of Magdeburg, Germany
  • Jan Buer, Prof. Dr. med., University of Duisburg, Germany
  • Edit Buzas, Prof. Dr. med., Semmelweis University, Hungary
  • Renato Damatta, Prof. PhD, UENF, Brazil
  • Maria Deli, MD, PhD, DSc, Biological Research Center, HAS, Hungary
  • Olgica Djurković-Djaković, Prof. Phd, University of Belgrade, Serbia
  • Jean-Dennis Docquier, Prof. Dr. med., University of Siena, Italy
  • Zsuzsanna Fabry, Prof. Phd, University of Washington, USA
  • Ralf Ignatius, Prof. Dr. med., Charité - University Medicine Berlin, Germany
  • Achim Kaasch, Prof. Dr. med., Otto von Guericke University Magdeburg, Germany
  • Oliver Liesenfeld, Prof. Dr. med., Inflammatix, USA
  • Matyas Sandor, Prof. PhD, University of Wisconsin, USA
  • Ulrich Steinhoff, Prof. PhD, University of Marburg, Germany
  • Michal Toborek, Prof. PhD, University of Miami, USA
  • Susanne A. Wolf, PhD, MDC-Berlin, Germany

 

Dr. Dunay, Ildiko Rita
Magdeburg, Germany
E-mail: ildiko.dunay@med.ovgu.de

Indexing and Abstracting Services:

  • PubMed Central
  • Scopus
  • ESCI
  • CABI
  • CABELLS Journalytics

 

2023  
Web of Science  
Total Cites
WoS
674
Journal Impact Factor 3.3
Rank by Impact Factor

Q2

Impact Factor
without
Journal Self Cites
3.1
5 Year
Impact Factor
3.2
Scimago  
Scimago
H-index
15
Scimago
Journal Rank
0.601
Scimago Quartile Score Microbiology (medical) (Q2)
Microbiology (Q3)
Immunology and Allergy (Q3)
Immunology (Q3)
Scopus  
Scopus
Cite Score
5.0
Scopus
CIte Score Rank
Microbiology (medical) Q2
Scopus
SNIP
0.832

 

European Journal of Microbiology and Immunology
Publication Model Gold Open Access
Online only
Submission Fee none
Article Processing Charge 900 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Gold Open Access
Purchase per Title  

European Journal of Microbiology and Immunology
Language English
Size A4
Year of
Foundation
2011
Volumes
per Year
1
Issues
per Year
4
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 2062-509X (Print)
ISSN 2062-8633 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Sep 2024 0 44 8
Oct 2024 0 75 14
Nov 2024 0 29 12
Dec 2024 0 30 14
Jan 2025 0 36 15
Feb 2025 0 32 3
Mar 2025 0 0 0